Last updated on 10 May 2024
Owner Info
Alexion Pharmaceuticals, Inc.
121 Seaport Boulevard
Boston MA 02210, UNITED STATES OF AMERICA
Serial Number
2239927 filed on 30 Nov 2021
Correspondent
Maury M. Tepper, III
Tepper & Eyster, PLLC,,
3724 Benson Drive,
UNITED STATES OF AMERICA
2239927
30 Nov 2021
NA
WORD
8 Jun 2021
US
Status Date | Action Taken |
---|---|
10th May 2024 | Status change to Voided |
23rd Mar 2022 | International Registration in Australia Protected correspondence sent |
22nd Mar 2022 | IP Right Registration Published |
22nd Mar 2022 | Status change to Registered/Protected |
14th Jan 2022 | Application Accepted correspondence sent |
13th Jan 2022 | IP Right has been Examined |
13th Jan 2022 | IP Right Acceptance Published |
13th Jan 2022 | Status change to Accepted |
4th Jan 2022 | Awaiting examination |
4th Jan 2022 | Examination expedited |